Real-time enrollment status for this fatty liver disease clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 5:17 AM UTC
| NCT Number | NCT06318169 |
| Recruiting Status | Recruiting |
| Condition | Fatty Liver Disease |
| Phase | Clinical Trial |
| Target Enrollment | 1,050 participants |
| Active Locations | 107 sites in the US |
| Sponsor | 89bio, Inc. |
| Last Updated on CT.gov | February 11, 2026 (Feb 11, 2026) |
As of April 17, 2026: Clinical trial NCT06318169 is currently recruiting participants. This clinical trial study for fatty liver disease is actively seeking new participants at 107 locations across the United States. The study is sponsored by 89bio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06318169 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 107 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06318169 was last updated Feb 11, 2026 (February 11, 2026). HelloStudys verifies this status automatically.